Clinical Trials Browser

Completed × Biliary Tract Neoplasms × surufatinib × Clear all

NCT02966821 2019-02-27

Study of Surufatinib as Second-line Treatment in Patients With Biliary Tract Carcinoma

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms